CATHERINE GAINES: Open Payments
NPI 1063458941 · LUMBERTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$627 in 30 payments from 19 companies in 2025. Trend: 2023 $938 · 2024 $513 · 2025 $627
Food & beverage: $596Education: $31
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 5 | $118 |
| Novartis Pharmaceuticals Corporation | 3 | $84 |
| Janssen Biotech, Inc. | 4 | $76 |
| SOBI, INC | 2 | $47 |
| Ipsen Biopharmaceuticals, Inc | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $29 |
| BeOne Medicines USA, Inc. | 1 | $29 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Eisai Inc. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
Products named: ERLEADA, LUTATHERA, IBRANCE, Vonjo, BOSULIF, Onivyde, FRUZAQLA, BRUKINSA.
Industry payments across NC — which companies pay providers there.
